Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccination

Introduction: This study evaluated the durability of humoral and cell-mediated immunity (CMI) post Pfizer vaccination among healthcare workers (HCWs) at a tertiary care center in Lebanon. Methodology: A total of 42 HCWs were enrolled, with their past infection and/or vaccination duration ranging...

Full description

Saved in:
Bibliographic Details
Main Authors: Lina Ghandour, Wissam Yaacoub, George F Araj
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2025-05-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/20732
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849329255365738496
author Lina Ghandour
Wissam Yaacoub
George F Araj
author_facet Lina Ghandour
Wissam Yaacoub
George F Araj
author_sort Lina Ghandour
collection DOAJ
description Introduction: This study evaluated the durability of humoral and cell-mediated immunity (CMI) post Pfizer vaccination among healthcare workers (HCWs) at a tertiary care center in Lebanon. Methodology: A total of 42 HCWs were enrolled, with their past infection and/or vaccination duration ranging between 2 months and 2 years. Blood samples were tested for COVID CMI and humoral immunity simultaneously. Testing for COVID CMI was done by measuring the interferon gamma-release assay (IGRA) using the QuantiFERON SARS-CoV-2 test, and for COVID humoral immunity using the lateral flow Cellex qSARS-CoV-2 IgG/IgM Rapid Test. Results: The study group was 69% female and 31% male, aged 22–51 years. SARS-CoV-2 was contracted by 33 (78%) HCWs. Positive COVID humoral IgG and CMI response were found among 35 (83.3%) and 19 (45.2%) HCWs, respectively. Combining the findings for both tests revealed concordant positivity in 35.7%, concordant negativity in 7.1%, Pos IgG – Neg IGRA in 47.6%, and Neg IgG – Pos IGRA in 9.5%. Conclusions: Generally, no correlation was established between humoral and CMI responses following COVID-19 vaccination. That only 83.3% and 45.2% among the Pfizer-vaccinated HCWs tested positive for COVID humoral and CMI, respectively, prevents substantial conclusions about test reliability for determining immunity status post vaccination. Whether these results are influenced by the specific antigenic epitopes used in the tests or by the potential deterioration of the immune response over time remains to be determined. The incongruity between humoral and CMI responses post-vaccination suggests the need for more comprehensive testing methodologies to assess post-vaccination immunity.
format Article
id doaj-art-018cb757f7394f2091fd2ef4f74f7833
institution Kabale University
issn 1972-2680
language English
publishDate 2025-05-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-018cb757f7394f2091fd2ef4f74f78332025-08-20T03:47:19ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802025-05-01190510.3855/jidc.20732Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccinationLina Ghandour0Wissam Yaacoub1George F Araj2Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, LebanonDepartment of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, LebanonDepartment of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon Introduction: This study evaluated the durability of humoral and cell-mediated immunity (CMI) post Pfizer vaccination among healthcare workers (HCWs) at a tertiary care center in Lebanon. Methodology: A total of 42 HCWs were enrolled, with their past infection and/or vaccination duration ranging between 2 months and 2 years. Blood samples were tested for COVID CMI and humoral immunity simultaneously. Testing for COVID CMI was done by measuring the interferon gamma-release assay (IGRA) using the QuantiFERON SARS-CoV-2 test, and for COVID humoral immunity using the lateral flow Cellex qSARS-CoV-2 IgG/IgM Rapid Test. Results: The study group was 69% female and 31% male, aged 22–51 years. SARS-CoV-2 was contracted by 33 (78%) HCWs. Positive COVID humoral IgG and CMI response were found among 35 (83.3%) and 19 (45.2%) HCWs, respectively. Combining the findings for both tests revealed concordant positivity in 35.7%, concordant negativity in 7.1%, Pos IgG – Neg IGRA in 47.6%, and Neg IgG – Pos IGRA in 9.5%. Conclusions: Generally, no correlation was established between humoral and CMI responses following COVID-19 vaccination. That only 83.3% and 45.2% among the Pfizer-vaccinated HCWs tested positive for COVID humoral and CMI, respectively, prevents substantial conclusions about test reliability for determining immunity status post vaccination. Whether these results are influenced by the specific antigenic epitopes used in the tests or by the potential deterioration of the immune response over time remains to be determined. The incongruity between humoral and CMI responses post-vaccination suggests the need for more comprehensive testing methodologies to assess post-vaccination immunity. https://jidc.org/index.php/journal/article/view/20732COVID-19humoral immunitycell-mediated immunity
spellingShingle Lina Ghandour
Wissam Yaacoub
George F Araj
Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccination
Journal of Infection in Developing Countries
COVID-19
humoral immunity
cell-mediated immunity
title Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccination
title_full Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccination
title_fullStr Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccination
title_full_unstemmed Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccination
title_short Assessing COVID IGRA and IgG antibodies in healthcare workers post vaccination
title_sort assessing covid igra and igg antibodies in healthcare workers post vaccination
topic COVID-19
humoral immunity
cell-mediated immunity
url https://jidc.org/index.php/journal/article/view/20732
work_keys_str_mv AT linaghandour assessingcovidigraandiggantibodiesinhealthcareworkerspostvaccination
AT wissamyaacoub assessingcovidigraandiggantibodiesinhealthcareworkerspostvaccination
AT georgefaraj assessingcovidigraandiggantibodiesinhealthcareworkerspostvaccination